Intet billede af Jesper Østergaard
20072019

Publikationer pr. år

Netværk

Niels H. H. Heegaard

  • Statens Serum Institut

Ekstern person

Frank Larsen

  • H. Lundbeck A/S

Ekstern person

Arto Urtti

  • University of Helsinki

Ekstern person

Peter Westh

  • Roskilde University

Ekstern person

Michael Rappolt

  • Austrian Academy of Sciences

Ekstern person

Ian G. Tucker

  • University of Otago

Ekstern person

Christelle Hureau

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Arto Urtti

  • University of Helsinki

Ekstern person

Rene Holm

  • H. Lundbeck A/S

Ekstern person

Kaisa Naelapää

  • Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.

Ekstern person

Peter Faller

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Gunnar Houen

  • Statens Serum Institut

Ekstern person

Rene Holm

  • H.Lundbeck A/S

Ekstern person

Andrew R Phillips

  • AstraZeneca

Ekstern person

Rune A. Hartvig

  • Roskilde University

Ekstern person

Pernilla Åkesson

  • AstraZeneca

Ekstern person

Lasse Saaby

  • AstraZeneca

Ekstern person

Christian Schönbeck

  • H. Lundbeck A/S

Ekstern person

Anu J Airaksinen

  • Helsinki University

Ekstern person

Richard A Barker

  • AsraZeneca
  • University of Cambridge

Ekstern person

Jaakko Aaltonen

  • University of Helsinki

Ekstern person

Rene Holm

  • Institut for Farmaci

Ekstern person

Jørgen Wittendorff

  • Ferring Pharmaceuticals

Ekstern person

Isabelle Sasaki

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Bertil Abrahamsson

  • AstraZeneca

Ekstern person

Britta Polentarutti

  • AstraZeneca

Ekstern person

M. Murillo-Arbizu

  • University of Navarra

Ekstern person

Johan Nagstrup

  • Technical University of Denmark

Ekstern person

Karsten Petersson

  • LEO-Pharma

Ekstern person

Hu Zhang

  • University of Otago

Ekstern person

Peter Westh

  • Roskilde University

Ekstern person

Lin Yang

  • FARMA
  • Xi'an Jiaotong University

Ekstern person

Jian Wu

  • Department of Micro- and Nanotechnology, Technical University of Denmark

Ekstern person

Stephane Dubant

  • Waters France

Ekstern person

Wei Shi

  • Uppsala University

Ekstern person

Paul A Dickinson

  • AstraZeneca

Ekstern person

Martin Malmsten

  • Uppsala University

Ekstern person

S. Amézqueta

  • University of Navarra

Ekstern person

Charlotte Vermehren

  • LiPlasome Pharma A/S

Ekstern person

Janne Weisell

  • University of Eastern Finland

Ekstern person

Olivier Cuvillier

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Claus Larsen

  • University of Helsinki

Ekstern person

Annika Sarnes

  • University of Helsinki

Ekstern person

Anja Boisen

  • Technical University of Denmark

Ekstern person

Mats Johansson

  • Waters Sverige

Ekstern person

Madeleine Jensen

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Leena Peltonen

  • Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsink

Ekstern person

J. Paul Fawcett

  • University of Otago

Ekstern person

Pierre Bouquerel

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Annukka Kallinen

  • University of Helsinki

Ekstern person

Pasi Laurinmäki

  • University of Helsinki

Ekstern person

Sarah J Butcher

  • University of Helsinki

Ekstern person

Michael Ankersen

  • Novo Nordisk A/S (Biz)

Ekstern person

Lin Yang

  • University of Otago

Ekstern person

Bertil Abrahmsson

  • AstraZenecca

Ekstern person

Brianda Barrios-Lopez

  • University of Helsinki

Ekstern person

Manuel A. Méndez

  • Ecole Polytechnique Féderal de Lausanne

Ekstern person

René Holm

  • H. Lundbeck A/S

Ekstern person

Bertil Abrahamsson

  • AstraZeneca

Ekstern person

Rune B. Frederiksen

  • Waters Danmark

Ekstern person

Hubert H. Girault

  • Ecole Polytechnique Féderal de Lausanne

Ekstern person

Anne Canning

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Søren Hvidt

  • Roskilde University

Ekstern person

Katarina Edwards

  • Uppsala University

Ekstern person

Henrik V. Nicolajsen

  • H. Lundbeck A/S

Ekstern person

Kim Daasbjerg

  • Aarhus Universitet

Ekstern person

Henrik V. Nicolajsen

  • H.Lundbeck A/S

Ekstern person

Charlotte Vermehren

  • LiPlasome Pharma A/S

Ekstern person

Thomas Vilhelmsen

  • Novo Nordisk A/S (Biz)

Ekstern person

Arzu Selen

  • Food and Drug Administration

Ekstern person

Wei Wu

  • Fudan University

Ekstern person

Christian Schou

  • Statens Serum Institut

Ekstern person

Wei He

  • Fudan University

Ekstern person

James Lenke

  • Paraytec, Ltd

Ekstern person

Mette Høg Gaunø

  • Ferring Pharmaceuticals A/S

Ekstern person

René Holm

  • H.Lundbeck A/S

Ekstern person

Poul Bertelsen

  • Takeda Pharma A/S

Ekstern person

Noemi Rozlosnik

  • Department of Micro- and Nanotechnology, Technical University of Denmark

Ekstern person

Mechthild Schmitt

  • University of Helsinki

Ekstern person

Yi Lu

  • Fudan University

Ekstern person

E. González-Peñas

  • University of Navarra

Ekstern person

Crilles Casper Larsen

  • Ferring International Center

Ekstern person

Sune Askjær

  • H. Lundbeck A/S

Ekstern person

Jouni Hirvonen

  • University of Helsinki

Ekstern person

Johnny Eriksson

  • Uppsala University

Ekstern person

Milan Vasák

  • University of Zurich

Ekstern person

Anja G. Ohlsson

  • Institut for Farmaci

Ekstern person

Kim Bergström

  • University of Helsinki

Ekstern person

Anna Juréus

  • AstraZeneca

Ekstern person

Sabri Chiha

  • Université Fédérale Toulouse Midi-Pyrénées

Ekstern person

Stephan Sylvest Keller

  • Technical University of Denmark

Ekstern person

Mari Raki

  • University of Helsinki

Ekstern person